nodes	percent_of_prediction	percent_of_DWPC	metapath
Candesartan—PTGS1—Montelukast—chronic obstructive pulmonary disease	0.182	0.287	CbGbCtD
Candesartan—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.105	0.165	CbGbCtD
Candesartan—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0965	0.152	CbGbCtD
Candesartan—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0965	0.152	CbGbCtD
Candesartan—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0731	0.115	CbGbCtD
Candesartan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.0416	0.0657	CbGbCtD
Candesartan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0393	0.0621	CbGbCtD
Candesartan—Pranlukast—TNF—chronic obstructive pulmonary disease	0.00267	0.375	CrCbGaD
Candesartan—Irbesartan—CYP1A2—chronic obstructive pulmonary disease	0.00121	0.17	CrCbGaD
Candesartan—Losartan—ACE—chronic obstructive pulmonary disease	0.0011	0.154	CrCbGaD
Candesartan—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.000981	0.00386	CcSEcCtD
Candesartan—Rhinitis—Formoterol—chronic obstructive pulmonary disease	0.000981	0.00386	CcSEcCtD
Candesartan—Rhinitis—Arformoterol—chronic obstructive pulmonary disease	0.000981	0.00386	CcSEcCtD
Candesartan—Pharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.000971	0.00382	CcSEcCtD
Candesartan—Pharyngitis—Formoterol—chronic obstructive pulmonary disease	0.000971	0.00382	CcSEcCtD
Candesartan—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.000971	0.00382	CcSEcCtD
Candesartan—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.0038	CcSEcCtD
Candesartan—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.000966	0.0038	CcSEcCtD
Candesartan—Sinusitis—Salbutamol—chronic obstructive pulmonary disease	0.000965	0.0038	CcSEcCtD
Candesartan—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.000964	0.00379	CcSEcCtD
Candesartan—Oedema peripheral—Arformoterol—chronic obstructive pulmonary disease	0.000964	0.00379	CcSEcCtD
Candesartan—Oedema peripheral—Formoterol—chronic obstructive pulmonary disease	0.000964	0.00379	CcSEcCtD
Candesartan—Rhinitis—Montelukast—chronic obstructive pulmonary disease	0.000961	0.00378	CcSEcCtD
Candesartan—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.000959	0.00377	CcSEcCtD
Candesartan—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.000959	0.00377	CcSEcCtD
Candesartan—Hepatitis—Montelukast—chronic obstructive pulmonary disease	0.000958	0.00377	CcSEcCtD
Candesartan—Pharyngitis—Montelukast—chronic obstructive pulmonary disease	0.000951	0.00374	CcSEcCtD
Candesartan—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.000949	0.00374	CcSEcCtD
Candesartan—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.000946	0.00372	CcSEcCtD
Candesartan—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.000939	0.0037	CcSEcCtD
Candesartan—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000937	0.00369	CcSEcCtD
Candesartan—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.000933	0.00367	CcSEcCtD
Candesartan—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000928	0.00365	CcSEcCtD
Candesartan—Rhinitis—Salbutamol—chronic obstructive pulmonary disease	0.000926	0.00364	CcSEcCtD
Candesartan—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000924	0.00364	CcSEcCtD
Candesartan—Cough—Tiotropium—chronic obstructive pulmonary disease	0.000921	0.00362	CcSEcCtD
Candesartan—Valsartan—ALB—chronic obstructive pulmonary disease	0.00092	0.129	CrCbGaD
Candesartan—Pharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.000917	0.00361	CcSEcCtD
Candesartan—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000912	0.00359	CcSEcCtD
Candesartan—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.000911	0.00359	CcSEcCtD
Candesartan—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000906	0.00356	CcSEcCtD
Candesartan—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000906	0.00356	CcSEcCtD
Candesartan—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.00354	CcSEcCtD
Candesartan—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.00354	CcSEcCtD
Candesartan—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.000898	0.00354	CcSEcCtD
Candesartan—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.000891	0.00351	CcSEcCtD
Candesartan—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000871	0.00343	CcSEcCtD
Candesartan—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000863	0.0034	CcSEcCtD
Candesartan—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000863	0.0034	CcSEcCtD
Candesartan—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000858	0.00338	CcSEcCtD
Candesartan—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00337	CcSEcCtD
Candesartan—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00337	CcSEcCtD
Candesartan—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000853	0.00336	CcSEcCtD
Candesartan—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000852	0.00335	CcSEcCtD
Candesartan—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000852	0.00335	CcSEcCtD
Candesartan—Cardiac failure congestive—Prednisolone—chronic obstructive pulmonary disease	0.000845	0.00332	CcSEcCtD
Candesartan—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.000841	0.00331	CcSEcCtD
Candesartan—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00084	0.0033	CcSEcCtD
Candesartan—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000824	0.00324	CcSEcCtD
Candesartan—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000824	0.00324	CcSEcCtD
Candesartan—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000813	0.0032	CcSEcCtD
Candesartan—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.00319	CcSEcCtD
Candesartan—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000804	0.00316	CcSEcCtD
Candesartan—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000804	0.00316	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000785	0.00309	CcSEcCtD
Candesartan—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000778	0.00306	CcSEcCtD
Candesartan—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000778	0.00306	CcSEcCtD
Candesartan—Losartan—CYP1A2—chronic obstructive pulmonary disease	0.000778	0.109	CrCbGaD
Candesartan—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000778	0.00306	CcSEcCtD
Candesartan—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000773	0.00304	CcSEcCtD
Candesartan—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000762	0.003	CcSEcCtD
Candesartan—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000758	0.00298	CcSEcCtD
Candesartan—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000753	0.00296	CcSEcCtD
Candesartan—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000753	0.00296	CcSEcCtD
Candesartan—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000747	0.00294	CcSEcCtD
Candesartan—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.000744	0.00293	CcSEcCtD
Candesartan—Cough—Arformoterol—chronic obstructive pulmonary disease	0.000743	0.00292	CcSEcCtD
Candesartan—Cough—Formoterol—chronic obstructive pulmonary disease	0.000743	0.00292	CcSEcCtD
Candesartan—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000737	0.0029	CcSEcCtD
Candesartan—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.000735	0.00289	CcSEcCtD
Candesartan—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.000735	0.00289	CcSEcCtD
Candesartan—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00289	CcSEcCtD
Candesartan—Cough—Montelukast—chronic obstructive pulmonary disease	0.000728	0.00286	CcSEcCtD
Candesartan—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000726	0.00286	CcSEcCtD
Candesartan—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.000725	0.00285	CcSEcCtD
Candesartan—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000723	0.00284	CcSEcCtD
Candesartan—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.00284	CcSEcCtD
Candesartan—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000722	0.00284	CcSEcCtD
Candesartan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.00284	CcSEcCtD
Candesartan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000722	0.00284	CcSEcCtD
Candesartan—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000711	0.0028	CcSEcCtD
Candesartan—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00071	0.00279	CcSEcCtD
Candesartan—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00071	0.00279	CcSEcCtD
Candesartan—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000708	0.00279	CcSEcCtD
Candesartan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00277	CcSEcCtD
Candesartan—Cough—Salbutamol—chronic obstructive pulmonary disease	0.000702	0.00276	CcSEcCtD
Candesartan—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.000694	0.00273	CcSEcCtD
Candesartan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00269	CcSEcCtD
Candesartan—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00269	CcSEcCtD
Candesartan—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000685	0.00269	CcSEcCtD
Candesartan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000684	0.00269	CcSEcCtD
Candesartan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000682	0.00269	CcSEcCtD
Candesartan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000681	0.00268	CcSEcCtD
Candesartan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.000678	0.00267	CcSEcCtD
Candesartan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.000678	0.00267	CcSEcCtD
Candesartan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000667	0.00262	CcSEcCtD
Candesartan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000649	0.00256	CcSEcCtD
Candesartan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000649	0.00256	CcSEcCtD
Candesartan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000646	0.00254	CcSEcCtD
Candesartan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000645	0.00254	CcSEcCtD
Candesartan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000641	0.00252	CcSEcCtD
Candesartan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.0025	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000633	0.00249	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000633	0.00249	CcSEcCtD
Candesartan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000625	0.00246	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00062	0.00244	CcSEcCtD
Candesartan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00062	0.00244	CcSEcCtD
Candesartan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00062	0.00244	CcSEcCtD
Candesartan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000618	0.00243	CcSEcCtD
Candesartan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.00243	CcSEcCtD
Candesartan—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000614	0.00242	CcSEcCtD
Candesartan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000613	0.00241	CcSEcCtD
Candesartan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00241	CcSEcCtD
Candesartan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00241	CcSEcCtD
Candesartan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000611	0.00241	CcSEcCtD
Candesartan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000609	0.0024	CcSEcCtD
Candesartan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000605	0.00238	CcSEcCtD
Candesartan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000604	0.00238	CcSEcCtD
Candesartan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.0006	0.00236	CcSEcCtD
Candesartan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.0006	0.00236	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.0006	0.00569	CbGpPWpGaD
Candesartan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000599	0.00236	CcSEcCtD
Candesartan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000599	0.00236	CcSEcCtD
Candesartan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000599	0.00236	CcSEcCtD
Candesartan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000598	0.00235	CcSEcCtD
Candesartan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000589	0.00232	CcSEcCtD
Candesartan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000588	0.00231	CcSEcCtD
Candesartan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000587	0.00231	CcSEcCtD
Candesartan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000585	0.0023	CcSEcCtD
Candesartan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000583	0.0023	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000582	0.00229	CcSEcCtD
Candesartan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000581	0.00229	CcSEcCtD
Candesartan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.00228	CcSEcCtD
Candesartan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.00227	CcSEcCtD
Candesartan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000576	0.00227	CcSEcCtD
Candesartan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000575	0.00226	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000573	0.00544	CbGpPWpGaD
Candesartan—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000573	0.00543	CbGpPWpGaD
Candesartan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000572	0.00225	CcSEcCtD
Candesartan—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00057	0.00224	CcSEcCtD
Candesartan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00057	0.00224	CcSEcCtD
Candesartan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00224	CcSEcCtD
Candesartan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00224	CcSEcCtD
Candesartan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000567	0.00223	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000566	0.00537	CbGpPWpGaD
Candesartan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000566	0.00223	CcSEcCtD
Candesartan—AGTR1—Arf6 signaling events—EGFR—chronic obstructive pulmonary disease	0.000563	0.00534	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.000561	0.00533	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000557	0.00219	CcSEcCtD
Candesartan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000552	0.00217	CcSEcCtD
Candesartan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000552	0.00217	CcSEcCtD
Candesartan—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000552	0.00524	CbGpPWpGaD
Candesartan—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000551	0.00523	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.000549	0.00522	CbGpPWpGaD
Candesartan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.00216	CcSEcCtD
Candesartan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000549	0.00216	CcSEcCtD
Candesartan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000549	0.00216	CcSEcCtD
Candesartan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000549	0.00216	CcSEcCtD
Candesartan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000548	0.00216	CcSEcCtD
Candesartan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000543	0.00214	CcSEcCtD
Candesartan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000543	0.00214	CcSEcCtD
Candesartan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000542	0.00213	CcSEcCtD
Candesartan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000541	0.00213	CcSEcCtD
Candesartan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00054	0.00212	CcSEcCtD
Candesartan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00212	CcSEcCtD
Candesartan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000538	0.00212	CcSEcCtD
Candesartan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000537	0.00211	CcSEcCtD
Candesartan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000533	0.0021	CcSEcCtD
Candesartan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.00053	0.00209	CcSEcCtD
Candesartan—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000523	0.00497	CbGpPWpGaD
Candesartan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000521	0.00205	CcSEcCtD
Candesartan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00204	CcSEcCtD
Candesartan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000519	0.00204	CcSEcCtD
Candesartan—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	0.000515	0.00489	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000514	0.00488	CbGpPWpGaD
Candesartan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000512	0.00201	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000505	0.00479	CbGpPWpGaD
Candesartan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000499	0.00196	CcSEcCtD
Candesartan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000499	0.00196	CcSEcCtD
Candesartan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000492	0.00194	CcSEcCtD
Candesartan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000492	0.00194	CcSEcCtD
Candesartan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000488	0.00192	CcSEcCtD
Candesartan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000482	0.0019	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000476	0.00452	CbGpPWpGaD
Candesartan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000476	0.00187	CcSEcCtD
Candesartan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000476	0.00187	CcSEcCtD
Candesartan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000471	0.00185	CcSEcCtD
Candesartan—UGT1A3—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000469	0.00445	CbGpPWpGaD
Candesartan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000469	0.00184	CcSEcCtD
Candesartan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000466	0.00183	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000465	0.00442	CbGpPWpGaD
Candesartan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00183	CcSEcCtD
Candesartan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00046	0.00181	CcSEcCtD
Candesartan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00046	0.00181	CcSEcCtD
Candesartan—PTGS1—Overview of nanoparticle effects—TNF—chronic obstructive pulmonary disease	0.000456	0.00432	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000453	0.0043	CbGpPWpGaD
Candesartan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00045	0.00177	CcSEcCtD
Candesartan—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00045	0.00177	CcSEcCtD
Candesartan—Losartan—ALB—chronic obstructive pulmonary disease	0.000449	0.0631	CrCbGaD
Candesartan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000449	0.00177	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000446	0.00424	CbGpPWpGaD
Candesartan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.00174	CcSEcCtD
Candesartan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000442	0.00174	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.00044	0.00418	CbGpPWpGaD
Candesartan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00172	CcSEcCtD
Candesartan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00172	CcSEcCtD
Candesartan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.00172	CcSEcCtD
Candesartan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000438	0.00172	CcSEcCtD
Candesartan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000435	0.00171	CcSEcCtD
Candesartan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000435	0.00171	CcSEcCtD
Candesartan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000434	0.00171	CcSEcCtD
Candesartan—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000434	0.00171	CcSEcCtD
Candesartan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000433	0.0017	CcSEcCtD
Candesartan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00169	CcSEcCtD
Candesartan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000429	0.00169	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.000427	0.00405	CbGpPWpGaD
Candesartan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000426	0.00168	CcSEcCtD
Candesartan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000423	0.00166	CcSEcCtD
Candesartan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.00166	CcSEcCtD
Candesartan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00042	0.00165	CcSEcCtD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.000419	0.00397	CbGpPWpGaD
Candesartan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.00164	CcSEcCtD
Candesartan—UGT1A3—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000416	0.00395	CbGpPWpGaD
Candesartan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000414	0.00163	CcSEcCtD
Candesartan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00163	CcSEcCtD
Candesartan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000413	0.00163	CcSEcCtD
Candesartan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000413	0.00162	CcSEcCtD
Candesartan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000413	0.00162	CcSEcCtD
Candesartan—CYP2C8—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000411	0.0039	CbGpPWpGaD
Candesartan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000411	0.00162	CcSEcCtD
Candesartan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000404	0.00159	CcSEcCtD
Candesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.000403	0.00382	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000402	0.00382	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000401	0.00381	CbGpPWpGaD
Candesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.000399	0.00378	CbGpPWpGaD
Candesartan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.00157	CcSEcCtD
Candesartan—UGT1A3—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000397	0.00377	CbGpPWpGaD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000397	0.00377	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000391	0.00372	CbGpPWpGaD
Candesartan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00039	0.00153	CcSEcCtD
Candesartan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000387	0.00152	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000385	0.00365	CbGpPWpGaD
Candesartan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000385	0.00152	CcSEcCtD
Candesartan—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000379	0.00359	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000373	0.00354	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000368	0.00349	CbGpPWpGaD
Candesartan—PTGS1—Overview of nanoparticle effects—IL6—chronic obstructive pulmonary disease	0.000368	0.00349	CbGpPWpGaD
Candesartan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000367	0.00145	CcSEcCtD
Candesartan—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000367	0.00348	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000365	0.00346	CbGpPWpGaD
Candesartan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000364	0.00143	CcSEcCtD
Candesartan—UGT1A3—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.00036	0.00341	CbGpPWpGaD
Candesartan—UGT1A3—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000346	0.00328	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000344	0.00327	CbGpPWpGaD
Candesartan—UGT1A3—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000341	0.00324	CbGpPWpGaD
Candesartan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000338	0.00133	CcSEcCtD
Candesartan—CYP2C8—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000338	0.00321	CbGpPWpGaD
Candesartan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000337	0.00133	CcSEcCtD
Candesartan—AGTR1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000335	0.00318	CbGpPWpGaD
Candesartan—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000335	0.00132	CcSEcCtD
Candesartan—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000335	0.00318	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000333	0.00316	CbGpPWpGaD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000327	0.00311	CbGpPWpGaD
Candesartan—AGTR1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000326	0.00309	CbGpPWpGaD
Candesartan—AGTR1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000326	0.00309	CbGpPWpGaD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000326	0.00309	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000323	0.00307	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000323	0.00306	CbGpPWpGaD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000322	0.00306	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000319	0.00303	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000317	0.00301	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000314	0.00298	CbGpPWpGaD
Candesartan—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00031	0.00122	CcSEcCtD
Candesartan—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00121	CcSEcCtD
Candesartan—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000301	0.00119	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000299	0.00284	CbGpPWpGaD
Candesartan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.00118	CcSEcCtD
Candesartan—PTGS1—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	0.000295	0.0028	CbGpPWpGaD
Candesartan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000292	0.00277	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000292	0.00277	CbGpPWpGaD
Candesartan—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000289	0.00114	CcSEcCtD
Candesartan—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000288	0.00274	CbGpPWpGaD
Candesartan—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00112	CcSEcCtD
Candesartan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00112	CcSEcCtD
Candesartan—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000284	0.00112	CcSEcCtD
Candesartan—AGTR1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000279	0.00265	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000278	0.00264	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000276	0.00262	CbGpPWpGaD
Candesartan—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000275	0.00261	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000275	0.00261	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000268	0.00254	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000267	0.00253	CbGpPWpGaD
Candesartan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000267	0.00105	CcSEcCtD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000265	0.00252	CbGpPWpGaD
Candesartan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000264	0.00104	CcSEcCtD
Candesartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000252	0.00239	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000252	0.00239	CbGpPWpGaD
Candesartan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000981	CcSEcCtD
Candesartan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.00098	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000247	0.00234	CbGpPWpGaD
Candesartan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000246	0.000967	CcSEcCtD
Candesartan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000948	CcSEcCtD
Candesartan—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000238	0.00226	CbGpPWpGaD
Candesartan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000934	CcSEcCtD
Candesartan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000933	CcSEcCtD
Candesartan—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000237	0.00225	CbGpPWpGaD
Candesartan—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000236	0.000928	CcSEcCtD
Candesartan—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000928	CcSEcCtD
Candesartan—AGTR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000235	0.00223	CbGpPWpGaD
Candesartan—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000235	0.00223	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000231	0.00219	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	0.000227	0.00215	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000227	0.00215	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—ALB—chronic obstructive pulmonary disease	0.000226	0.00215	CbGpPWpGaD
Candesartan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000224	0.00088	CcSEcCtD
Candesartan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000224	0.00088	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000224	0.00212	CbGpPWpGaD
Candesartan—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000855	CcSEcCtD
Candesartan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000851	CcSEcCtD
Candesartan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000851	CcSEcCtD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000216	0.00205	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000215	0.00204	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000213	0.00203	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.00021	0.002	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000208	0.00198	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000206	0.00195	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000206	0.00195	CbGpPWpGaD
Candesartan—PTGS1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000205	0.00195	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000205	0.00194	CbGpPWpGaD
Candesartan—AGTR1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000199	0.00189	CbGpPWpGaD
Candesartan—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000772	CcSEcCtD
Candesartan—PTGS1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000195	0.00185	CbGpPWpGaD
Candesartan—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000194	0.000762	CcSEcCtD
Candesartan—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000193	0.00183	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000191	0.00181	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000189	0.0018	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000188	0.00178	CbGpPWpGaD
Candesartan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000187	0.000737	CcSEcCtD
Candesartan—UGT1A3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000184	0.00175	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	0.000184	0.00175	CbGpPWpGaD
Candesartan—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000712	CcSEcCtD
Candesartan—UGT1A3—Metabolism—GC—chronic obstructive pulmonary disease	0.000179	0.0017	CbGpPWpGaD
Candesartan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000684	CcSEcCtD
Candesartan—CYP2C8—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000173	0.00164	CbGpPWpGaD
Candesartan—Rash—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000679	CcSEcCtD
Candesartan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000678	CcSEcCtD
Candesartan—AGTR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000172	0.00163	CbGpPWpGaD
Candesartan—Headache—Prednisone—chronic obstructive pulmonary disease	0.000171	0.000674	CcSEcCtD
Candesartan—CYP2C8—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000171	0.00162	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00017	0.00161	CbGpPWpGaD
Candesartan—UGT1A3—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000169	0.00161	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000168	0.00159	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000167	0.00158	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000166	0.00158	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000164	0.00156	CbGpPWpGaD
Candesartan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000162	0.000639	CcSEcCtD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000161	0.00152	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000157	0.00149	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000146	0.00139	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000144	0.00137	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000142	0.00135	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000141	0.00134	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000139	0.00132	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	0.000134	0.00127	CbGpPWpGaD
Candesartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000133	0.00127	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000133	0.00126	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000132	0.00125	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000131	0.00124	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000126	0.0012	CbGpPWpGaD
Candesartan—CYP2C8—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000126	0.00119	CbGpPWpGaD
Candesartan—CYP2C8—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000124	0.00118	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000119	0.00113	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000119	0.00113	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000118	0.00112	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000118	0.00112	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000116	0.0011	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000113	0.00107	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000112	0.00106	CbGpPWpGaD
Candesartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00011	0.00105	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000108	0.00103	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000108	0.00102	CbGpPWpGaD
Candesartan—PTGS1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	0.000108	0.00102	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000107	0.00101	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000106	0.00101	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000104	0.000985	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000103	0.000977	CbGpPWpGaD
Candesartan—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000102	0.000972	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000102	0.000965	CbGpPWpGaD
Candesartan—AGTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000102	0.000964	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	0.000101	0.000961	CbGpPWpGaD
Candesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.000101	0.000961	CbGpPWpGaD
Candesartan—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000101	0.000958	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GC—chronic obstructive pulmonary disease	0.000101	0.000958	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.79e-05	0.000929	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.68e-05	0.000919	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	9.65e-05	0.000916	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	9.57e-05	0.000908	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.39e-05	0.000891	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	9.29e-05	0.000882	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	8.83e-05	0.000838	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	8.82e-05	0.000837	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	8.78e-05	0.000833	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	8.44e-05	0.000801	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	8.24e-05	0.000782	CbGpPWpGaD
Candesartan—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.2e-05	0.000778	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.14e-05	0.000772	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	7.48e-05	0.00071	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	7.43e-05	0.000705	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.22e-05	0.000685	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	6.91e-05	0.000656	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.79e-05	0.000644	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.7e-05	0.000636	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.69e-05	0.000635	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.65e-05	0.000631	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	6.52e-05	0.000619	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.38e-05	0.000605	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.24e-05	0.000592	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.06e-05	0.000575	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.91e-05	0.000561	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	5.87e-05	0.000557	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.84e-05	0.000554	CbGpPWpGaD
Candesartan—AGTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	5.74e-05	0.000545	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	5.7e-05	0.000541	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	5.68e-05	0.000539	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.52e-05	0.000524	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.46e-05	0.000518	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GCLC—chronic obstructive pulmonary disease	5.45e-05	0.000518	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	5.41e-05	0.000514	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	5.31e-05	0.000504	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.28e-05	0.000501	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.21e-05	0.000495	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.18e-05	0.000492	CbGpPWpGaD
Candesartan—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.08e-05	0.000483	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	4.99e-05	0.000473	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CTGF—chronic obstructive pulmonary disease	4.98e-05	0.000472	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.93e-05	0.000468	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.83e-05	0.000459	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.72e-05	0.000448	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	4.63e-05	0.00044	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.58e-05	0.000435	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.53e-05	0.00043	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.33e-05	0.000411	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.25e-05	0.000403	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.05e-05	0.000384	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	4.02e-05	0.000382	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	3.93e-05	0.000373	CbGpPWpGaD
Candesartan—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.84e-05	0.000365	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.82e-05	0.000363	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.81e-05	0.000362	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.77e-05	0.000358	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.64e-05	0.000345	CbGpPWpGaD
Candesartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.57e-05	0.000339	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.56e-05	0.000338	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	3.52e-05	0.000334	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.51e-05	0.000333	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.47e-05	0.00033	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.33e-05	0.000316	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.28e-05	0.000312	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	3.21e-05	0.000305	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.1e-05	0.000295	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.08e-05	0.000292	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.07e-05	0.000291	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.96e-05	0.000281	CbGpPWpGaD
Candesartan—AGTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.93e-05	0.000278	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.9e-05	0.000275	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	2.87e-05	0.000272	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	2.8e-05	0.000266	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.79e-05	0.000264	CbGpPWpGaD
Candesartan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.72e-05	0.000258	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	2.67e-05	0.000254	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	2.62e-05	0.000248	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.58e-05	0.000245	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.5e-05	0.000237	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.47e-05	0.000234	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.44e-05	0.000231	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.41e-05	0.000229	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.3e-05	0.000218	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.27e-05	0.000215	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—ALB—chronic obstructive pulmonary disease	2.26e-05	0.000215	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.25e-05	0.000214	CbGpPWpGaD
Candesartan—PTGS1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.17e-05	0.000206	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.15e-05	0.000204	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.15e-05	0.000204	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.12e-05	0.000201	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.01e-05	0.000191	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.98e-05	0.000188	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.98e-05	0.000188	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.89e-05	0.000179	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.87e-05	0.000178	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.85e-05	0.000175	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.75e-05	0.000166	CbGpPWpGaD
Candesartan—AGTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.73e-05	0.000164	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	1.46e-05	0.000139	CbGpPWpGaD
Candesartan—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	1.4e-05	0.000133	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.27e-05	0.000121	CbGpPWpGaD
Candesartan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.22e-05	0.000116	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000113	CbGpPWpGaD
Candesartan—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000108	CbGpPWpGaD
